Press Release

19 Nov 2026

London Vet Show 2026: FluoretiQ opens Veri-5 Vet partnership with money-back offer

FluoretiQ Stand: H72
London Vet Show 2026: FluoretiQ opens Veri-5 Vet partnership with money-back offer
Fluoretiq London Vet Show special offer
FluoretiQ, the University of Bristol spinout developing rapid point-of-care bacterial diagnostics, will exhibit at London Vet Show 2026 at ExCeL London on 19–20 November. On Stand H72, the team will invite UK practices to apply for its Technology Access Partnership (TAP) programme, which gives practices early, hands-on access to Veri-5 Vet in their own clinic.

 Veri-5 Vet identifies the most common bacteria behind urinary tract infections (UTIs) in dogs and cats in approximately 15 minutes, right in the practice. As a London Vet Show offer, independent practices that join TAP will get a 30 day money-back guarantee (terms apply).

Answers during the consultation, not days later

When a dog or cat shows signs of a urinary tract infection, sending a urine sample to an external laboratory for culture can mean waiting days for results. In the meantime, vets often have to start treatment before they know which bacteria are involved. Repeat courses mean more visits for the pet and more antibiotic use.

Veri-5 Vet is designed to bring bacterial identification into the consultation. The practice team adds a prepared urine sample to a Veri-5 cartridge, loads it into the analyser and presses start. In approximately 15 minutes, Veri-5 Vet identifies the most common UTI-causing bacteria in dogs and cats, with 91% sensitivity and 92% specificity.

That gives veterinary teams useful diagnostic information earlier in the clinical journey, to support informed treatment decisions and antimicrobial stewardship.

London Vet Show offer: 30-day money-back guarantee

Independent practices that join TAP through London Vet Show will get priority access and a one-month money-back guarantee (terms apply). TAP gives practices early, hands-on access to Veri-5 Vet in their own clinic, so they can see how in-practice bacterial ID fits their UTI workflow.

Practices can talk to the team about TAP on Stand H72 throughout the show, or apply now at https://www.fluoretiq.com/veri-5-vet/.

What's on at Stand H72

  • Talk to the FluoretiQ team about joining TAP and the one-month money-back guarantee
  • Take a short UTI diagnostics quiz and pick up a free succulent (while stocks last)

Award-winning technology

The show follows FluoretiQ's first-place finish at the Hong Kong MedTech Innovation World Cup 2026 in March. With Veri-5 Vet, FluoretiQ beat more than 210 companies and was the only finalist of 11 presenting a veterinary product.

Visit FluoretiQ

About FluoretiQ

FluoretiQ Limited develops rapid point-of-care bacterial diagnostics to help tackle antimicrobial resistance. It was founded in 2017 as a spinout from the University of Bristol and is headquartered in Bristol. Its veterinary product, Veri-5 Vet, identifies the most common bacteria behind UTIs in dogs and cats at the point of care. www.fluoretiq.com

Questions about TAP? Email us info@fluoretiq.com


View all Press Release
Loading
Hero Image

Education Partners

royal veterinary college university of london logo    british veterinary association logo 

Sponsors

diamond
platinum


silver